Onconetix Inc.
Organization details
- Legal name
- Onconetix Inc.
- Former names
- Blue Water Biotech, Inc. Blue Water Vaccines Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Cincinnati
- Headquarters state / province
- Ohio
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ONCO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001782107
Board of directors
-
Ajit Singh · DirectorSince 2024
-
Andrew John Oakley · DirectorSince 2025
-
James Sapirstein · DirectorSince 2023
-
Joseph Hernandez · Director · CEOSince 2023
-
Neil J. Campbell · Director · Chief Executive OfficerSince 2023
-
Sammy Dorf · DirectorSince 2026
-
Sarah Romano · DirectorSince 2025
-
Simon Tarsh · DirectorSince 2023
-
Thomas Meier · DirectorSince 2024
-
Timothy R. Ramdeen · DirectorSince 2023
-
Vuk Jeremic · DirectorSince 2023
Chief executives
Director election results
Annual meeting of December 5, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
97.6%
-
98.5%
Board connections
6 of this board's directors also sit on 9 other boards. 2 are in the same sector.
- via James Sapirstein and Timothy R. Ramdeen
- via Andrew John Oakley and Timothy R. Ramdeen
- via Vuk Jeremic
- via Joseph Hernandez
- via Joseph Hernandez
-
INmune Bio Inc. Same sectorvia James Sapirstein
-
Lunai Bioworks Inc. Same sectorvia James Sapirstein
- via Vuk Jeremic
- via Sammy Dorf
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $152,875
- 3 purchases by 1 insider
- Sold, last 12 months
- $144,469
- 3 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 21, 2026 | HRT FINANCIAL LP 10% owner | Open-market sale | −49,710 | $0.69 | $34,300 |
| Apr 20, 2026 | HRT FINANCIAL LP 10% owner | Open-market sale | −94,462 | $0.75 | $70,847 |
| Apr 17, 2026 | HRT FINANCIAL LP 10% owner | Open-market purchase | +34,636 | $0.73 | $25,284 |
| Apr 16, 2026 | HRT FINANCIAL LP 10% owner | Open-market sale | −53,867 | $0.73 | $39,323 |
| Apr 15, 2026 | HRT FINANCIAL LP 10% owner | Open-market purchase | +92,554 | $0.76 | $70,341 |
| Apr 14, 2026 | HRT FINANCIAL LP 10% owner | Open-market purchase | +74,350 | $0.77 | $57,250 |
| Aug 15, 2025 | Andrew John Oakley Director | Other | +20 | — | — |
| Aug 15, 2025 | Simon Tarsh Director | Other | +39 | — | — |
| Aug 15, 2025 | Thomas Meier Director | Other | +39 | — | — |
| Aug 15, 2025 | Timothy R. Ramdeen Director | Other | +39 | — | — |
| Aug 15, 2025 | Andrew John Oakley Director | Grant or award | +618 | — | — |
| Aug 15, 2025 | Simon Tarsh Director | Grant or award | +618 | — | — |
| Aug 15, 2025 | Thomas Meier Director | Grant or award | +618 | — | — |
| Aug 15, 2025 | Timothy R. Ramdeen Director | Grant or award | +618 | — | — |
| Jul 14, 2025 | Altos Venture AG 10% owner | Other | +241,514 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Onconetix Inc.
Who is the CEO of Onconetix Inc.?
Neil J. Campbell has been Onconetix Inc.'s Chief Executive Officer since October 2023.
How many directors are on Onconetix Inc.'s board?
Onconetix Inc.'s board has 11 directors: Ajit Singh, Andrew John Oakley, James Sapirstein, Joseph Hernandez, Neil J. Campbell, Sammy Dorf, Sarah Romano, Simon Tarsh, Thomas Meier, Timothy R. Ramdeen and 1 other.
Are Onconetix Inc. insiders buying or selling shares?
Over the last 12 months, Onconetix Inc. insiders bought $152,875 of shares in 3 purchases and sold $144,469 of shares in 3 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="onconetix-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.